Generic Name and Formulations:
Mometasone furoate 0.1%; crm; oint.
Merck & Co., Inc.
Indications for ELOCON:
Adults and Children:
<2yrs: not recommended. ≥2yrs: apply thin film once daily; max 3 weeks' therapy for children. Discontinue when control is achieved. Do not occlude.
Avoid use near eyes, on face, groin, or axillae. Do not use for diaper dermatitis. Risk of HPA axis suppression with high-potency steroids, prolonged use, application to large surface area, use of occlusive dressings, altered skin barrier, liver failure, young age; discontinue gradually, or reduce dose or potency if occurs. Increased risk of posterior subcapsular cataracts and glaucoma; monitor for visual symptoms. Treat infection if present; discontinue if infection persists or worsens. Reevaluate periodically. Pregnancy (Cat.C). Nursing mothers.
Burning, pruritus, skin atrophy, tingling/stinging, furunculosis, acneiform reaction, folliculitis; allergic contact dermatitis (discontinue if irritation occurs), HPA axis suppression (esp. in children); rare: Cushing's syndrome, hyperglycemia.
Oint—15g, 45g; Crm—15g, 50g; Lotion—30mL, 60mL
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Lithium Monotherapy Effective in Treating Bipolar Disorder in Children
- Computerized Training Programs for Schizophrenia Improve Cognitive Functioning
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Cognitive Behavioral Therapy May Alter Suicidal Ideation in Anxiety Disorders
- Ketamine Infusions Reduce Suicidal Ideation in Depression: Characterizing Different Responses
- Brief Impression Questionnaire Useful in Schizophrenia Diagnoses
- Autism Spectrum Disorders Associated With Depression in Young Adults
- Gestational Diabetes Associated With Increased Risk for Postpartum Depression
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Smartphone-Based Psychoeducational Programs May Be Effective for Bipolar Disorder Management